<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="158210">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02089893</url>
  </required_header>
  <id_info>
    <org_study_id>CRA-8504-1/2014/EKU</org_study_id>
    <nct_id>NCT02089893</nct_id>
  </id_info>
  <brief_title>Study of the Incidence of Cilioretinal Arteries in the Hungarian Population</brief_title>
  <official_title>Study of the Incidence of Cilioretinal Arteries in the Hungarian Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Semmelweis University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Semmelweis University</source>
  <oversight_info>
    <authority>Hungary: Scientific and Research Ethics Committee of the Medical Research Council</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to analyze the retinal arteries, to investigate the incidence,
      number, types, distribution and localization of cilioretinal arteries in the Hungarian
      Caucasian population.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">February 2015</completion_date>
  <primary_completion_date type="Anticipated">February 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Cross-Sectional</study_design>
  <primary_outcome>
    <measure>Incidence of cilioretinal arteries</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Cilioretinal Arteries</condition>
  <arm_group>
    <arm_group_label>Healthy subjects</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy young population
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Caucasian race

          -  Signed informed consent

        Exclusion Criteria:

          -  Optical media opacities of the eye
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Miklos Schneider, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Semmelweis University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Miklos Schneider, MD, PhD</last_name>
    <phone>+36208258458</phone>
    <email>schneider.miklos@med.semmelweis-univ.hu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Semmelweis University, Department of Ophthalmology</name>
      <address>
        <city>Budapest</city>
        <zip>1085</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miklos Schneider, MD, PhD</last_name>
      <phone>+36208258458</phone>
      <email>schneider.miklos@med.semmelweis-univ.hu</email>
    </contact>
    <investigator>
      <last_name>Miklos Schneider, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andras Papp, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dorottya Szabo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Janos Nemeth, MD, PhD, DSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Hungary</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 15, 2014</lastchanged_date>
  <firstreceived_date>March 15, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Semmelweis University</investigator_affiliation>
    <investigator_full_name>Miklos Schneider MD, PhD</investigator_full_name>
    <investigator_title>Assistant lecturer</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
